These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1325217)

  • 21. Specificity of colon specific antigen and colon ovarian tumour antigen.
    Dorman AM; Chin D; Leader M
    J Clin Pathol; 1992 Oct; 45(10):932-3. PubMed ID: 1385484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of GATA3 Versus BRST2 for the Identification of Metastatic Breast Carcinoma in the Upper GI Tract: Which Performs Better?
    Salagean D; Streutker C; Faragalla H; Jakate K
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):501-507. PubMed ID: 29629946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.
    Luo MH; Huang YH; Ni YB; Tsang JY; Chan SK; Shao MM; Tse GM
    Hum Pathol; 2013 Jul; 44(7):1241-50. PubMed ID: 23332923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
    Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
    Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
    J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral breast cancer: one disease or two?
    Dawson PJ; Maloney T; Gimotty P; Juneau P; Ownby H; Wolman SR
    Breast Cancer Res Treat; 1991 Nov; 19(3):233-44. PubMed ID: 1663803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of alpha-lactalbumin in human breast cancer tissue.
    Simícková M; Lang BA; Rejthar A; Cernoch M; Sakalová J; Pacovský Z
    Neoplasma; 1989; 36(1):11-20. PubMed ID: 2539567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical diagnosis of occult breast cancer].
    Schmitz FJ; Bosse U
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):249-53. PubMed ID: 3036640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.
    Heyderman E; Strudley I; Powell G; Richardson TC; Cordell JL; Mason DY
    Br J Cancer; 1985 Sep; 52(3):355-61. PubMed ID: 3899156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
    Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
    Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
    Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
    Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples.
    Codington JF; Haavik S; Nikrui N; Kuter I; Vassileva C; Zhang H; Matson S; Chen X; Wu Z
    Cancer; 2002 Feb; 94(3):803-13. PubMed ID: 11857316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
    Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
    Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
    Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
    Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma.
    Byrne J; Horgan PG; England S; Callaghan J; Given HF
    Eur J Cancer; 1992; 28(2-3):658-60. PubMed ID: 1591088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
    Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
    Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Sox10 labeling in metastatic breast carcinomas.
    Nelson ER; Sharma R; Argani P; Cimino-Mathews A
    Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
    Pires Y; Andrade L; Cuello M; Chuaqui R
    Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.